Noble E. Jarrell

Array ( [id] => 62983 [patent_doc_number] => 07763602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Pyrrole derivatives as antimycobacterial compounds' [patent_app_type] => utility [patent_app_number] => 12/137170 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12873 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763602.pdf [firstpage_image] =>[orig_patent_app_number] => 12137170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949918 [patent_doc_number] => 20080306044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'SPIROBENZOAZEPANES AS VASOPRESSIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/134291 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25718 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306044.pdf [firstpage_image] =>[orig_patent_app_number] => 12134291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909419 [patent_doc_number] => 08481484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Cyclic heptapeptide and use of the same' [patent_app_type] => utility [patent_app_number] => 12/675485 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13230 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9944288 [patent_doc_number] => 08993588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Carboxamide heterocyclic CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/602676 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17040 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760104 [patent_doc_number] => 08420626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof' [patent_app_type] => utility [patent_app_number] => 12/601867 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17035 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151974 [patent_doc_number] => 07678807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Isoquinoline and benzo[H] isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine H3 receptor' [patent_app_type] => utility [patent_app_number] => 12/122795 [patent_app_country] => US [patent_app_date] => 2008-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6702 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678807.pdf [firstpage_image] =>[orig_patent_app_number] => 12122795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6443517 [patent_doc_number] => 20100144588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'PROTON ACCEPTOR IMINIUM/CARBOCATION-TYPE COUPLING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/451496 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26211 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144588.pdf [firstpage_image] =>[orig_patent_app_number] => 12451496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386191 [patent_doc_number] => 08263586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'OXO bridged diazepan orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/599925 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840459 [patent_doc_number] => 20080280945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Crystalline forms of an HIV integrase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/151744 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18429 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280945.pdf [firstpage_image] =>[orig_patent_app_number] => 12151744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698933 [patent_doc_number] => 20080221117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'UREA DERIVATIVES AS CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 12/116920 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15282 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221117.pdf [firstpage_image] =>[orig_patent_app_number] => 12116920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948949 [patent_doc_number] => 20080305075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs' [patent_app_type] => utility [patent_app_number] => 12/111672 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 40205 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305075.pdf [firstpage_image] =>[orig_patent_app_number] => 12111672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728089 [patent_doc_number] => 20080207633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'UREA DERIVATIVES AS CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 12/111131 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15292 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207633.pdf [firstpage_image] =>[orig_patent_app_number] => 12111131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813927 [patent_doc_number] => 20080194558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Quinazoline analogs as receptor Tyrosine Kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/081725 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15903 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194558.pdf [firstpage_image] =>[orig_patent_app_number] => 12081725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564744 [patent_doc_number] => 20090137597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Novel quinoxalinone derivatives' [patent_app_type] => utility [patent_app_number] => 12/081773 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57715 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137597.pdf [firstpage_image] =>[orig_patent_app_number] => 12081773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417094 [patent_doc_number] => 20090042981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES' [patent_app_type] => utility [patent_app_number] => 12/105016 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20473 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042981.pdf [firstpage_image] =>[orig_patent_app_number] => 12105016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421805 [patent_doc_number] => 08278293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Diazo bicyclic Smac mimetics and the uses thereof' [patent_app_type] => utility [patent_app_number] => 12/159249 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 37288 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12159249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859092 [patent_doc_number] => 20080267942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'BENZAZEPIN-2(1H)-ONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/101317 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39563 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267942.pdf [firstpage_image] =>[orig_patent_app_number] => 12101317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603809 [patent_doc_number] => 20100063030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Benzenesulfonyl Compounds and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/595066 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21507 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063030.pdf [firstpage_image] =>[orig_patent_app_number] => 12595066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603809 [patent_doc_number] => 20100063030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Benzenesulfonyl Compounds and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/595066 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21507 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063030.pdf [firstpage_image] =>[orig_patent_app_number] => 12595066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162685 [patent_doc_number] => 07671082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Prodrugs of excitatory amino acids' [patent_app_type] => utility [patent_app_number] => 12/059112 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48934 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671082.pdf [firstpage_image] =>[orig_patent_app_number] => 12059112 [rel_patent_id] =>[rel_patent_doc_number] =>)